Paul J. Mellett
2015
In 2015, Paul J. Mellett earned a total compensation of $1.5M as Senior Vice President, Finance & Administration and Chief Financial Officer at Enanta Pharmaceuticals, a 15% increase compared to previous year.
Compensation breakdown
Bonus | $122,542 |
---|---|
Option Awards | $960,157 |
Salary | $344,862 |
Stock Awards | $86,158 |
Other | $15,706 |
Total | $1,529,425 |
Mellett received $960.2K in option awards, accounting for 63% of the total pay in 2015.
Mellett also received $122.5K in bonus, $344.9K in salary, $86.2K in stock awards and $15.7K in other compensation.
Rankings
In 2015, Paul J. Mellett's compensation ranked 5,885th out of 13,638 executives tracked by ExecPay. In other words, Mellett earned more than 56.8% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 5,885 | 57th |
Manufacturing | 2,191 | 58th |
Chemicals And Allied Products | 792 | 57th |
Drugs | 632 | 59th |
Pharmaceutical Preparations | 495 | 58th |
Mellett's colleagues
We found two more compensation records of executives who worked with Paul J. Mellett at Enanta Pharmaceuticals in 2015.
News
Enanta Pharmaceuticals CEO Jay Luly's 2022 pay jumps 37% to $7.3M
January 20, 2023
Enanta Pharmaceuticals CEO Jay Luly's 2021 pay rises 2% to $5.3M
January 21, 2022
Enanta Pharmaceuticals CEO Jay Luly's 2020 pay rises 16% to $5.2M
January 21, 2021
Enanta Pharmaceuticals CEO Jay Luly's 2019 pay slips 1% to $4.5M
January 17, 2020
Enanta Pharmaceuticals CEO Jay Luly's 2018 pay rises 5% to $4.5M
January 18, 2019